AstraZeneca

Legal Entities

• AstraZeneca AB

Overview

AstraZeneca plc was formed in 1999 through the merger of Swedish Astra AB and British Zeneca Group, headquartered in Cambridge, England. It focuses on oncology, cardiovascular, renal, metabolism, and respiratory science.

UK trademark registration aligns with major biopharmaceutical brands and clinical trial code names that may become commercial. AstraZeneca's public profile rose with pandemic vaccine deployment, illustrating how short-term public communication still depends on underlying registered marks and regulatory labelling.

Visit AstraZeneca website →